Can a diabetes drug help kidney transplant patients lose weight safely?
NCT ID NCT07423247
First seen Mar 06, 2026 · Last updated May 14, 2026 · Updated 7 times
Summary
This study tests a weight-loss drug called tirzepatide (brand name Spartina) in 30 obese adults who have had a kidney transplant at least a year ago. The goal is to see if the drug helps them lose weight without harming their kidney function or causing serious side effects. Participants will take the drug for 24 weeks while doctors monitor weight changes, digestive issues, and levels of their anti-rejection medications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TIRZEPATIDE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nooshin Dalili
RECRUITINGTehran, Iran
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.